[go: up one dir, main page]

EE9500055A - 1,4-dihüdropüridiin-3,5-dikarboksüülhappeestrite kasutamine ravimitena, ravimid ja nende valmistamismeetod - Google Patents

1,4-dihüdropüridiin-3,5-dikarboksüülhappeestrite kasutamine ravimitena, ravimid ja nende valmistamismeetod

Info

Publication number
EE9500055A
EE9500055A EE9500055A EE9500055A EE9500055A EE 9500055 A EE9500055 A EE 9500055A EE 9500055 A EE9500055 A EE 9500055A EE 9500055 A EE9500055 A EE 9500055A EE 9500055 A EE9500055 A EE 9500055A
Authority
EE
Estonia
Prior art keywords
medicaments
dihydropyridine
preparation
dicarboxylic acid
acid esters
Prior art date
Application number
EE9500055A
Other languages
English (en)
Estonian (et)
Inventor
Urbahns Klaus
Behner Otto
Goldmann Siegfried
Heine Hans-Georg
Junge Bodo
Schohe-Loop Rudolf
Wehinger Egbert
Wollweber Hartmund
Sommermeyer Henning
Glaser Thomas
Wittka Reilinde
De Vry Jean-Marie-Viktor
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of EE9500055A publication Critical patent/EE9500055A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
EE9500055A 1994-08-25 1995-08-24 1,4-dihüdropüridiin-3,5-dikarboksüülhappeestrite kasutamine ravimitena, ravimid ja nende valmistamismeetod EE9500055A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4430094A DE4430094A1 (de) 1994-08-25 1994-08-25 Verwendung von 3,5-Dicarbonsäureester-1,4-Dihydropyridinen als Arzneimittel

Publications (1)

Publication Number Publication Date
EE9500055A true EE9500055A (et) 1996-04-15

Family

ID=6526498

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9500055A EE9500055A (et) 1994-08-25 1995-08-24 1,4-dihüdropüridiin-3,5-dikarboksüülhappeestrite kasutamine ravimitena, ravimid ja nende valmistamismeetod

Country Status (14)

Country Link
US (2) US5665741A (xx)
EP (1) EP0705819A1 (xx)
JP (1) JPH0859468A (xx)
KR (1) KR960007563A (xx)
CN (1) CN1128757A (xx)
AU (1) AU3011295A (xx)
CA (1) CA2156673A1 (xx)
DE (1) DE4430094A1 (xx)
EE (1) EE9500055A (xx)
FI (1) FI953957L (xx)
HU (1) HUT74617A (xx)
IL (1) IL115030A0 (xx)
NO (1) NO953322L (xx)
PL (1) PL310146A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078719A1 (en) * 1999-06-23 2000-12-28 Ajinomoto Co., Inc. Dihydropyridine derivative
ATE511858T1 (de) * 2002-02-05 2011-06-15 Astellas Pharma Inc 2,4,6-triamino-1,3,5-triazin-derivat
US20050075359A1 (en) * 2003-03-14 2005-04-07 Rikako Kono Large conductance calcium-activated K channel opener
AU2012342226B2 (en) * 2011-11-24 2017-09-28 Richter Gedeon Nyrt. 1,4- dihydropyridine derivatives with Hsp modulating activity
CN104710441B (zh) * 2014-12-18 2017-01-18 苏州科技学院 吡啶五甲酸二钾化合物及其制备方法
US20230416203A1 (en) * 2020-11-30 2023-12-28 Nanyang Technological University Potent and selective inhibitors of the calcium-activated potassium channel, kca3.1, for use as platform therapeutics

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1813436C3 (de) * 1968-12-07 1979-01-11 Bayer Ag, 5090 Leverkusen N-Substituierte 2,6-Dimethyl-l,4dihydropyridine
US3883543A (en) * 1969-05-10 1975-05-13 Bayer Ag N-alkyl-1,4-dihydropyridines
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
JPS4899181A (xx) * 1972-04-04 1973-12-15
DE2815578C2 (de) 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
EP0287828A1 (de) * 1987-03-27 1988-10-26 Byk Gulden Lomberg Chemische Fabrik GmbH Neue Zwischenprodukte und Verfahren
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
PL310146A1 (en) 1996-03-04
FI953957A7 (fi) 1996-02-26
NO953322L (no) 1996-02-26
US5665741A (en) 1997-09-09
FI953957L (fi) 1996-02-26
CN1128757A (zh) 1996-08-14
CA2156673A1 (en) 1996-02-26
JPH0859468A (ja) 1996-03-05
NO953322D0 (no) 1995-08-24
KR960007563A (ko) 1996-03-22
AU3011295A (en) 1996-03-07
IL115030A0 (en) 1995-12-08
US5955482A (en) 1999-09-21
HU9502509D0 (en) 1995-10-30
DE4430094A1 (de) 1996-02-29
FI953957A0 (fi) 1995-08-23
EP0705819A1 (de) 1996-04-10
HUT74617A (en) 1997-01-28

Similar Documents

Publication Publication Date Title
ATA102392A (de) Topisches terbinafinpräparat und verfahren zu seiner herstellung
FI940874A7 (fi) Menetelmä maitohapon ja maitohappoestereiden valmistamiseksi
DK680788D0 (da) Indolcarboxylsyreestere og -amider, deres fremstilling of laegemidler indeholdende forbindelserne
FI895910A7 (fi) Antiseptiset koostumukset ja menetelmä niiden valmistamiseksi
FI951387L (fi) Sulfonamidokarbonyylipyridiini-2-karboksyylihappoesteriamidit sekä niiden pyridiini-N-oksidit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
IT8848259A0 (it) 1,4-diidropiridine, loro procedimento di preparazione e loro applicazione come medicamenti
FI955175A0 (fi) Polyhydroksikarboksyylihapon valmistusmenetelmä
FI964901L (fi) Menetelmä alfa-metoksi-iminokarboksyylihappometyyliamidien valmistamiseksi ja menetelmässä käytettyjä välituotteita
FI953956A0 (fi) 2,3-rengaskondensoidut 1,4-dihydropyridiinit, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
EE9500055A (et) 1,4-dihüdropüridiin-3,5-dikarboksüülhappeestrite kasutamine ravimitena, ravimid ja nende valmistamismeetod
FR2549058B1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
ATE140455T1 (de) Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
KR900700452A (ko) 테트라히드로피리딘 유도체, 그를 함유하는 약학 조성물 및 그의 제조방법
DE69419674D1 (de) Optisch aktive 1,4-Dihydropyridinderivate und Verfahren zu ihrer Herstellung
AU3108393A (en) Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester, process for its preparation and its pharmaceutical use
FI956016A7 (fi) 1,2-silloitettujen 1,4-dihydropyridiinien käyttö lääkeaineina
FI933255A7 (fi) 1,4-dihydropyridiini-3,5-dikarboksyylihappoesteri, menetelmä sen valmistamiseksi ja sen farmaseuttinen käyttö
NO960777D0 (no) Anvendelse av N-alkylerte 1,4-dihydropyridin dikarboksylsyreestere som medikamenter
DE69509822D1 (de) Verfahren zur Herstellung von Ascorbinsäurederivaten
DE69527684D1 (de) Herstellung von 3-oxy-5-oxo-6-Heptensäurederivaten
FR2728902B1 (fr) Derives d'acide 8-oxo-5,8-dihydro-6h-dibenzo(a,g)quinolizine-13-propanoique, leur preparation et leur application en therapeutique
FI954394L (fi) 17-desoksikortikosteroidi-21-(O)-karboksyylihappoestereitä, menetelmä niiden valmistamiseksi ja niitä sisältäviä lääkkeitä
EE9400144A (et) Bispilokarphappe estri derivaadid ja nende valmistamismeetod
FI955825A7 (fi) Uusi, hyvin selektiivinen menetelmä enantiomeeripuhtaiden fenyylillä substituoitujen 1,4-dihydropyridiini-3,5-dikarboksyylihappojohdannaisten valmistamiseksi
FI843012A7 (fi) 3(1-Metyyli-5-nitro-2-imidatsolyyli)-2-asetyyli-propeenihapon dimetyyliesteri, sen valmistusmenetelmä ja terapeuttinen käyttö